Phillip Frost, a name synonymous with entrepreneurship and innovation, began his career in the early 1970s, fresh out of the University of Pennsylvania’s Wharton School. He started as an analyst at a small investment firm, his keen eye for detail and strategic thinking quickly setting him apart. It was during this time that he developed a strong interest in the healthcare industry, recognizing its potential for growth and innovation.

Frost’s big break came in 1984 when he co-founded Key Pharmaceuticals, a company focused on developing and marketing generic drugs. His vision was to make high-quality, affordable medications accessible to a wider range of patients. Under his leadership, Key Pharmaceuticals grew rapidly, becoming a major player in the industry and catching the attention of the broader business community.

Phillip Frost’s Current Net Worth (2025)

As of 2025, Phillip Frost’s current net worth is estimated to be around $6.5 billion, according to Forbes. This significant wealth is largely attributed to his successful career in the pharmaceutical industry and his strategic investments.

Career

Phillip Frost is a renowned American businessman and physician, best known for his role as the chairman and CEO of Ivax Corporation, a generic drug manufacturer. He co-founded the company in 1982 and led it until its acquisition by Teva Pharmaceutical Industries in 2006 for $7.4 billion. Frost is also a co-founder and chairman of OPKO Health, a biopharmaceutical company.

Other Ventures

Beyond his pharmaceutical endeavors, Frost has ventured into other industries. He is a co-owner of the Miami Dolphins, the National Football League team based in Miami, Florida. Additionally, he has invested in real estate, including the acquisition of the historic Betsy Hotel in South Beach, Miami.

Assets

Frost’s assets include a significant stake in OPKO Health, as well as investments in other public and private companies. He also owns a luxurious waterfront mansion in Miami Beach, Florida, valued at around $40 million, and a private jet. His art collection, which includes works by Andy Warhol and Roy Lichtenstein, is also a notable asset.

Annual Income

While Frost’s exact annual income is not publicly disclosed, it is estimated to be substantial due to his significant investments and business ventures. As of 2021, his compensation from OPKO Health alone was reported to be around $10 million, which includes his salary, bonus, and other compensation.

Frequently Asked Questions about  Phillip Frost

Frequently Asked Questions about Phillip Frost Net Worth

1. What is Phillip Frost’s net worth?

Phillip Frost’s net worth is estimated to be around $4.5 billion.

2. How did Phillip Frost make his fortune?

Phillip Frost made his fortune primarily through pharmaceuticals and investments. He co-founded Ivax Corporation, a generic drug manufacturer, in 1964, which he later sold to Teva Pharmaceutical Industries in 2005 for $7.4 billion.

3. What is Phillip Frost’s age?

Phillip Frost was born on July 19, 1935, making him 86 years old.

4. Where does Phillip Frost live?

Phillip Frost resides in Miami, Florida.

5. Is Phillip Frost married?

Yes, Phillip Frost is married. He has been married to his wife, Patricia, for over 50 years.

6. Does Phillip Frost have any children?

Yes, Phillip Frost has two children, a son named Phillip Frost Jr. and a daughter named Lisa Frost.

7. What is Phillip Frost’s educational background?

Phillip Frost graduated from the University of Miami with a Bachelor of Science degree in Pharmacy in 1957.

8. What are some of Phillip Frost’s philanthropic efforts?

Phillip Frost and his wife have made significant donations to various causes, including healthcare, education, and arts. They have established the Phillip and Patricia Frost Museum of Science in Miami and have also donated to the University of Miami’s Frost School of Music.

9. What is Phillip Frost’s political affiliation?

Phillip Frost is a registered Republican.

10. Has Phillip Frost faced any controversies?

Yes, Phillip Frost has faced controversies related to his business dealings. In 2018, he was involved in a stock promotion scheme that resulted in a $30 million fine and a ban from serving as an officer or director of a public company for five years.